If you are a HCP and would like to visit the global Hemophilia website, please confirm this by pressing the button below.
This website contains information based on the Summary of Product Characteristics (SPC), as approved by the European Commission on Jivi (damoctog alfa pegol), Kovaltry (octocog alfa) and Kogenate FS (octocog alfa). It is intended to provide information to an international audience. In countries outside the EU, the local Product Information applies.
Bayer is committed to supporting all stakeholders in the hemophilia community and provides a range of resources for healthcare professionals.
Download Resource Centre
See what Bayer is doing to help people with hemophilia to break boundaries, thrive and achieve their full potential.
© 2022 Bayer AG
This website is intended to provide information to an international audience outside the USA and UK
Last updated: June 2022